Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | Director | April 26, 2013 | April 30, 2013 |
| Walmart Inc.WMT · Entity 783 | Director | June 03, 2005 | June 07, 2005 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date April 26, 2013 · Filed April 30, 2013
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,520 |
Reported balance
After 2013-04-26 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2013-04-26 · Grant · Acquired 1,845 · Balance 25,520 F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. F2: These shares include 208 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.
F2: These shares include 208 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
Walmart Inc.
Report date June 03, 2005 · Filed June 07, 2005
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,898.71 |
Reported balance
After 2005-06-03 transaction · row 1
1 source rowRow 1 · 2005-06-03 · Grant · Acquired 2,956.71 · Balance 7,898.71 F1: Each outside director is entitled to $140,000 of stock as part of his or her annual retainer. |
Filing footnotes · ownership attribution and instrument terms
F1: Each outside director is entitled to $140,000 of stock as part of his or her annual retainer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 26, 2013 Filed Apr 30, 2013 22:06 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-014809 · form4.xml · nonDerivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,520 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. F2 · balance_after: These shares include 208 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| August 09, 2012 Filed Aug 13, 2012 22:56 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 4,500 | $81.93 | $368,692.20 |
DisclosureSEC source: 0001127602-12-024328 · form4.xml · nonDerivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,591 F1 · price: The price reported is an average price. The prices ranged from $81.931 to $81.932 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer. F2 · balance_after: These shares include 124 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's unvested, and vested but deferred, Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| August 06, 2012 Filed Aug 8, 2012 22:14 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $54.69 | $0.00 |
DisclosureSEC source: 0001127602-12-024125 · form4.xml · derivative · entry 15 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2012 Filed Aug 8, 2012 22:14 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $58.43 | $0.00 |
DisclosureSEC source: 0001127602-12-024125 · form4.xml · derivative · entry 14 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2020-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2012 Filed Aug 8, 2012 22:14 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-12-024125 · form4.xml · derivative · entry 13 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2016-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2012 Filed Aug 8, 2012 22:14 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $42.13 | $0.00 |
DisclosureSEC source: 0001127602-12-024125 · form4.xml · derivative · entry 12 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2015-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2012 Filed Aug 8, 2012 22:14 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $62.55 | $0.00 |
DisclosureSEC source: 0001127602-12-024125 · form4.xml · derivative · entry 11 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2014-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2012 Filed Aug 8, 2012 22:14 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 3,327 | $82.21 | $273,512.67 |
DisclosureSEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 10 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,091 F1 · balance_after: These shares include 124 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's unvested, and vested but deferred, Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| August 06, 2012 Filed Aug 8, 2012 22:14 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 3,554 | $82.21 | $292,174.34 |
DisclosureSEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 9 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,418 Read SEC document |
| August 06, 2012 Filed Aug 8, 2012 22:14 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 3,068 | $82.21 | $252,220.28 |
DisclosureSEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 8 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,972 Read SEC document |
| August 06, 2012 Filed Aug 8, 2012 22:14 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,563 | $82.21 | $210,704.23 |
DisclosureSEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 7 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,040 Read SEC document |
| August 06, 2012 Filed Aug 8, 2012 22:14 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 3,805 | $82.21 | $312,809.05 |
DisclosureSEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 6 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,603 Read SEC document |
| August 06, 2012 Filed Aug 8, 2012 22:14 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 5,000 | $54.69 | $273,450.00 |
DisclosureSEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 5 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2012 Filed Aug 8, 2012 22:14 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 5,000 | $58.43 | $292,150.00 |
DisclosureSEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 4 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2012 Filed Aug 8, 2012 22:14 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 5,000 | $50.44 | $252,200.00 |
DisclosureSEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 3 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2012 Filed Aug 8, 2012 22:14 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 5,000 | $42.13 | $210,650.00 |
DisclosureSEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 2 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2012 Filed Aug 8, 2012 22:14 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 5,000 | $62.55 | $312,750.00 |
DisclosureSEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2012 Filed Jul 31, 2012 23:21 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $71.64 | $0.00 |
DisclosureSEC source: 0001127602-12-023271 · form4.xml · derivative · entry 6 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2022-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2012 Filed Jul 31, 2012 23:21 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $74.89 | $0.00 |
DisclosureSEC source: 0001127602-12-023271 · form4.xml · derivative · entry 5 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2013-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2012 Filed Jul 31, 2012 23:21 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 4,269 | $83.92 | $358,254.48 |
DisclosureSEC source: 0001127602-12-023271 · form4.xml · nonDerivative · entry 4 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,408 F1 · balance_after: These shares include 124 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's unvested, and vested but deferred, Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| July 30, 2012 Filed Jul 31, 2012 23:21 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 4,462 | $83.92 | $374,451.04 |
DisclosureSEC source: 0001127602-12-023271 · form4.xml · nonDerivative · entry 3 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,677 Read SEC document |
| July 30, 2012 Filed Jul 31, 2012 23:21 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 5,000 | $71.64 | $358,200.00 |
DisclosureSEC source: 0001127602-12-023271 · form4.xml · nonDerivative · entry 2 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2012 Filed Jul 31, 2012 23:21 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 5,000 | $74.89 | $374,450.00 |
DisclosureSEC source: 0001127602-12-023271 · form4.xml · nonDerivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 27, 2012 Filed May 2, 2012 00:00 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 5,000 | $71.64 Strike: $71.64 | $358,200.00 |
DisclosureSEC source: 0001127602-12-015233 · form4.xml · derivative · entry 2 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2022-04-27 Read SEC document |
| April 27, 2012 Filed May 2, 2012 00:00 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-015233 · form4.xml · nonDerivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,107 F1 · shares: The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the "Director Program") and vested immediately because the director has three years or more of prior continuous service as a director. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. F2 · balance_after: These shares include 92 Dividend Equivalents ("DEs") granted pursuant to the Director Program. The acquisition of DEs had previously been reported in Table II of the director's Form 4 filings prior to the Company implementing a qualifying dividend reinvestment plan in 2012. DEs are credited on the director's unvested, and vested but deferred, RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 13, 2012 Filed Jan 13, 2012 21:12 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001127602-12-001727 · form4.xml · derivative · entry 3 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2012-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2012 Filed Jan 13, 2012 21:12 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 4,339 | $67.54 | $293,056.06 |
DisclosureSEC source: 0001127602-12-001727 · form4.xml · nonDerivative · entry 2 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,620 Read SEC document |
| January 13, 2012 Filed Jan 13, 2012 21:12 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 5,000 | $58.61 | $293,050.00 |
DisclosureSEC source: 0001127602-12-001727 · form4.xml · nonDerivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2011 Filed Dec 22, 2011 21:47 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $56.30 | $0.00 |
DisclosureSEC source: 0001127602-11-033106 · form4.xml · derivative · entry 3 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2012-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2011 Filed Dec 22, 2011 21:47 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 14,267 | $63.14 | $900,818.38 |
DisclosureSEC source: 0001127602-11-033106 · form4.xml · nonDerivative · entry 2 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,959 Read SEC document |
| December 22, 2011 Filed Dec 22, 2011 21:47 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 16,000 | $56.30 | $900,800.00 |
DisclosureSEC source: 0001127602-11-033106 · form4.xml · nonDerivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,226 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2011 Filed Dec 13, 2011 00:10 UTC | AMGEN INC AMGN · Entity 2832 | GrantDividend Equivalent · Derivative | 29.2282 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-031953 · form4.xml · derivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59.9366 Underlying: Common Stock · 29.2282 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| September 08, 2011 Filed Sep 12, 2011 21:36 UTC | AMGEN INC AMGN · Entity 2832 | GrantDividend Equivalent · Derivative | 30.7084 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-025065 · form4.xml · derivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30.7084 Underlying: Common Stock · 30.7084 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 25, 2011 Filed Apr 28, 2011 00:23 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 5,000 | $54.69 Strike: $54.69 | $273,450.00 |
DisclosureSEC source: 0001127602-11-013864 · form4.xml · derivative · entry 2 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2021-04-25 Read SEC document |
| April 25, 2011 Filed Apr 28, 2011 00:23 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-013864 · form4.xml · nonDerivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,226 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director has had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 22:30 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 5,000 | $58.43 Strike: $58.43 | $292,150.00 |
DisclosureSEC source: 0001127602-10-012358 · form4.xml · derivative · entry 2 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2020-04-26 Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 22:30 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,711 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012358 · form4.xml · nonDerivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,398 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's 2009 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director has had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| April 28, 2009 Filed Apr 30, 2009 16:05 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-09-010036 · form4.xml · derivative · entry 3 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2016-04-28 Read SEC document |
| April 28, 2009 Filed Apr 30, 2009 16:05 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,982 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-010036 · form4.xml · nonDerivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,982 F1 · security: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous services as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| April 29, 2008 Filed May 1, 2008 21:21 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 5,000 | $42.13 Strike: $42.13 | $210,650.00 |
DisclosureSEC source: 0001181431-08-028035 · rrd204641.xml · derivative · entry 2 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2015-04-29 Read SEC document |
| April 29, 2008 Filed May 1, 2008 21:21 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 2,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-08-028035 · rrd204641.xml · nonDerivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,705 F1 · security: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director hah had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| April 26, 2007 Filed Apr 30, 2007 17:30 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 5,000 | $62.55 Strike: $62.55 | $312,750.00 |
DisclosureSEC source: 0001181431-07-027931 · rrd156004.xml · derivative · entry 2 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2014-04-26 Read SEC document |
| April 26, 2007 Filed Apr 30, 2007 17:30 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,598 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-07-027931 · rrd156004.xml · nonDerivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,332 F1 · security: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| March 15, 2006 Filed Mar 16, 2006 20:53 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $74.89 | $0.00 |
DisclosureSEC source: 0001181431-06-018421 · rrd111490.xml · derivative · entry 2 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2013-03-15 Read SEC document |
| March 15, 2006 Filed Mar 16, 2006 20:53 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-06-018421 · rrd111490.xml · nonDerivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,734 F1 · balance_after: Include shares equivalent to Restricted Stock Units, which were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restarted 1991 Equity Incentive Plan, which were paid in shares of the Company's common stock on a one-to-one basis shortly after vesting, and whcih were previously identified as Restricted Stock Units on Table 1. Read SEC document |
| June 03, 2005 Filed Jun 7, 2005 18:24 UTC | Walmart Inc. WMT · Entity 783 | GrantCommon Stock | 2,956.71 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001252670-05-000062 · doc4.xml · nonDerivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,898.71 F1 · price: Each outside director is entitled to $140,000 of stock as part of his or her annual retainer. Read SEC document |
| March 15, 2005 Filed Mar 17, 2005 19:56 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001181431-05-017489 · rrd72842.xml · derivative · entry 3 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2015-03-15 Read SEC document |
| March 15, 2005 Filed Mar 17, 2005 19:56 UTC | AMGEN INC AMGN · Entity 2832 | GrantRestricted Stock Units | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-017489 · rrd72842.xml · nonDerivative · entry 2 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,706 F1 · security: (DIR 03.15.05) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| June 04, 2004 Filed Jun 8, 2004 22:23 UTC | Walmart Inc. WMT · Entity 783 | GrantCommon Stock | 2,032 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001252670-04-000065 · doc4.xml · nonDerivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,942 F1 · price: Each Outside Director is entitled to $115,000 of stock as part of his or her annual retainer. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:03 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right Buy) · Derivative | 5,000 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015950 · rrd36768.xml · derivative · entry 3 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2011-03-15 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.